Aerocrine Press Release: Interim Report January - June 2013

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Regulatory News:

Aerocrine (STO:AERO-B)

January – June 2013

•Global Net sales decreased by 9% to SEK 69.4m (76.0)*. Adjusted for currency fluctuations, net sales decreased by 5% Year over Year (Y-o-Y). ?Net sales for clinical use of NIOX MINO increased by 17% and in the US by 48% in local currency.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC